Skip to main content

SATURNA CAPITAL CORP

Position in JNJ — Johnson & Johnson

CIK 1316617 BELLINGHAM, WA

Position in JNJ

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$43,798,025
+$6,360,357 QoQ
Shares Held
179,177
-1.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 92.13961613376716.ToString("F0")% Shared 0.ToString("F0")% None 7.860383866232831.ToString("F0")%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

SATURNA CAPITAL CORP holds $1,020,494,047 across 8 Drug Manufacturers - General names. JNJ ranks #6 (4.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 JNJ
Johnson & Johnson
This page
179,177 $43,798,025

All Filings in JNJ

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $43,798,025 179,177
2025-12-31 $37,437,668 180,902
2025-09-30 $33,761,829 182,083
2025-06-30 $27,861,294 182,398
2025-03-31 $30,281,223 182,593
2024-12-31 $26,413,830 182,643
2024-09-30 $30,036,038 185,339
2024-06-30 $26,981,282 184,601
2024-03-31 $29,095,253 183,926
2023-12-31 $82,221,572 524,573
2023-09-30 $84,335,042 541,477
2023-06-30 $90,710,753 548,035
2023-03-31 $84,417,495 544,629
2022-12-31 $94,293,650 533,788
2022-09-30 $87,173,306 533,627
2022-06-30 $94,702,827 533,507
2022-03-31 $94,491,946 533,160
2021-12-31 $88,304,623 516,190
2021-09-30 $81,660,860 505,640
2021-06-30 $83,173,107 504,875
2021-03-31 $82,801,173 503,810
2020-12-31 $78,903,564 501,357
2020-09-30 $74,647,985 501,397
2020-06-30 $70,351,141 500,257
2020-03-31 $65,592,143 500,207